Inactive Instrument

Cornerstone Therapeutics, Inc. Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

28/02/14	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
03/02/14	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
31/01/14	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/11/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
31/10/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)
16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	31/12/2020
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.21%	-4.52%	+18.91%	+67.25%	48.26B
OTSUKA HOLDINGS CO., LTD.	+0.60%	-4.72%	+39.26%	+118.09%	40.5B
CIPLA LIMITED	+0.72%	-1.01%	-10.20%	+11.66%	11.85B
ZYDUS LIFESCIENCES LIMITED	+3.29%	-0.38%	+14.11%	+82.76%	11.83B
KRKA, D. D.	-1.50%	-0.38%	+24.76%	+138.18%	9.36B
GEDEON RICHTER	-0.86%	-3.20%	+23.76%	+38.38%	7.5B
ONO PHARMACEUTICAL CO., LTD.	-0.19%	-2.80%	+36.00%	-13.71%	7.37B
GLENMARK PHARMACEUTICALS LIMITED	+0.60%	-1.13%	+19.49%	+208.86%	7.28B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-0.32%	-1.85%	-46.31%	+22.01%	5.19B
Average	+0.25%	-2.35%	+13.31%	+74.83%	16.57B
Weighted average by Cap.	+0.30%	-1.85%	+20.96%	+82.21%